WATCH: Alessandro A. Viansone, MD, discusses balancing ADCs such as T-DXd against low-toxicity chemotherapy in HER2-positive breast cancer therapy de-escalation. @gustaveroussy.fr #bcsm #oncology www.onclive.com/view/dr-vian...